SEARCH RESULTS FOR: "Tag: MRK"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2023(6)
2022(12)
2021(8)
2020(5)
2019(19)
2018(18)
2017(27)
2016(26)
2015(15)
2014(5)
CATEGORIES
5-Minute Market Rundown(5)
Analyst Downgrades(4)
Analyst Update(9)
Analyst Upgrades(5)
Best and Worst Stocks(5)
Buzz Stocks(18)
By the Numbers(1)
Earnings Preview(1)
Editor's Pick(4)
Ezines(4)
General(3)
Intraday Option Activity(9)
Market Recap(18)
Midday Market Check(18)
Opening View(22)
Options Recommendations(2)
Podcast(1)
Quantitative Analysis(6)
Stock Market News(5)
Stocks On the Move(8)
Strategies and Concepts(2)
Technical Analysis(4)
The Week Ahead(10)
Trader Content(1)
Trader Content (1)

7/27/2023 12:30 PM
July comes to an official close next week, and August is already set to kick things off into high gear. Right off the bat, traders will have manufacturing data to unpack, which will be followed with a...
6/23/2023 8:49 AM
Subscribers to Chart of the Week received this commentary on Sunday, June 18. The biotech sector comes with a large ‘buyer beware’ sticker. Most stocks in the sector are prone to volatile moves depen...
4/13/2023 9:18 AM
Citigroup upgraded blue-chip pharma giant Merck & Co., Inc. (NYSE:MRK) to "buy" and hiked its price target to $130, citing "materially revised forecasts" for the company's experimental cancer treatm...
4/6/2023 10:26 AM
Subscribers to Chart of the Week received this commentary on Sunday, April 2. With the second quarterly fully underway, Schaeffer’s Senior Quantitative Analyst Rocky White pulled S&P 500 Index (S...
2/23/2023 11:17 AM
Moderna Inc (NASDAQ:MRNA) stock is down 7% at $147.10 at last check, after the company's lackluster fourth-quarter earnings report offset some upbeat Food and Drug Administration (FDA) news. Spec...